These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2959654)

  • 1. Isolation of Escherichia coli rpoB mutants resistant to killing by lambda cII protein and altered in pyrE gene attenuation.
    Hammer K; Jensen KF; Poulsen P; Oppenheim AB; Gottesman M
    J Bacteriol; 1987 Nov; 169(11):5289-97. PubMed ID: 2959654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired lysogenisation of the Escherichia coli rpoA341 mutant by bacteriophage lambda is due to the inability of CII to act as a transcriptional activator.
    Obuchowski M; Giladi H; Koby S; Szalewska-Pałasz A; Wegrzyn A; Oppenheim AB; Thomas MS; Wegrzyn G
    Mol Gen Genet; 1997 Apr; 254(3):304-11. PubMed ID: 9150265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of bacteriophage lambda CII activity by bacteriophage and host functions.
    Rattray A; Altuvia S; Mahajna G; Oppenheim AB; Gottesman M
    J Bacteriol; 1984 Jul; 159(1):238-42. PubMed ID: 6330032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lambda mutation in the Escherichia coli rho gene that inhibits the N protein activity of phage lambda.
    Das A; Gottesman ME; Wardwell J; Trisler P; Gottesman S
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5530-4. PubMed ID: 6225121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drastically decreased transcription from CII-activated promoters is responsible for impaired lysogenization of the Escherichia coli rpoA341 mutant by bacteriophage lambda.
    Szalewska-Pałasz A; Wegrzyn A; Obuchowski M; Pawłowski R; Bielawski K; Thomas MS; Wegrzyn G
    FEMS Microbiol Lett; 1996 Oct; 144(1):21-7. PubMed ID: 8870247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Escherichia coli RNA polymerase alpha subunit and transcriptional activation by bacteriophage lambda CII protein.
    Gabig M; Obuchowski M; Ciesielska A; Latała B; Wegrzyn A; Thomas MS; Wegrzyn G
    Acta Biochim Pol; 1998; 45(1):271-80. PubMed ID: 9701520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of the bacteriophage lambda cII gene product to Escherichia coli arises from inhibition of host cell DNA replication.
    Kedzierska B; Glinkowska M; Iwanicki A; Obuchowski M; Sojka P; Thomas MS; Wegrzyn G
    Virology; 2003 Sep; 313(2):622-8. PubMed ID: 12954227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli nusB mutations that suppress nusA1 exhibit lambda N specificity.
    Ward DF; DeLong A; Gottesman ME
    J Mol Biol; 1983 Jul; 168(1):73-85. PubMed ID: 6224023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of transcription termination signals in the nin region of bacteriophage lambda: the roc deletion.
    Leason KR; Friedman DI
    J Bacteriol; 1988 Nov; 170(11):5051-8. PubMed ID: 2972695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nus mutations affect transcription termination in Escherichia coli.
    Ward DF; Gottesman ME
    Nature; 1981 Jul; 292(5820):212-5. PubMed ID: 6265784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of conditionally lethal amber mutations affecting synthesis of the nusA protein of Escherichia coli.
    Nakamura Y; Uchida H
    Mol Gen Genet; 1983; 190(2):196-203. PubMed ID: 6308387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of a mutant derivative of the pRE promoter of bacteriophage lambda by its activator, CII.
    Gussin GN; Temple E; Brown SE; Court D
    Gene; 1986; 46(2-3):171-80. PubMed ID: 2948878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter for the establishment of repressor synthesis in bacteriophage lambda.
    Schmeissner U; Court D; Shimatake H; Rosenberg M
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3191-5. PubMed ID: 6447872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SeqA-mediated stimulation of a promoter activity by facilitating functions of a transcription activator.
    Słomińska M; Konopa G; Ostrowska J; Kedzierska B; Wegrzyn G; Wegrzyn A
    Mol Microbiol; 2003 Mar; 47(6):1669-79. PubMed ID: 12622820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-specificities between cII-like proteins and pRE-like promoters of lambdoid bacteriophages.
    Wulff DL; Mahoney ME
    Genetics; 1987 Apr; 115(4):597-604. PubMed ID: 2953649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Bacteriophage Lambda CII Phenotypes for Complementation, Cellular Toxicity and Replication Inhibition Are Suppressed in cII-oop Constructs Expressing the Small RNA OOP.
    Rajamanickam K; Hayes S
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29518935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CII-dependent activation of the pRE promoter of coliphage lambda fused to the Escherichia coli galK gene.
    Fien K; Turck A; Kang I; Kielty S; Wulff DL; McKenney K; Rosenberg M
    Gene; 1984 Dec; 32(1-2):141-50. PubMed ID: 6241579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The remarkable specificity of a new transcription termination factor suggests that the mechanisms of termination and antitermination are similar.
    Robert J; Sloan SB; Weisberg RA; Gottesman ME; Robledo R; Harbrecht D
    Cell; 1987 Nov; 51(3):483-92. PubMed ID: 2822258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage lambda cIII gene product has an additional function apart from inhibition of cII degradation.
    Latała B; Obuchowski M; W grzyn G
    Virus Genes; 2001 Mar; 22(2):127-32. PubMed ID: 11324748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phage lambda CII transcriptional activator carries a C-terminal domain signaling for rapid proteolysis.
    Kobiler O; Koby S; Teff D; Court D; Oppenheim AB
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14964-9. PubMed ID: 12397182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.